MUHAS

RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate

Retrieved on: 
Tuesday, April 16, 2024
Nursing, Education, Other Health, Health, General Health, Women, Radiology, Oncology, Medical Devices, Training, Consumer, Mortality, MUHAS, Cancer, Learning, Mammography, GE HealthCare, NNSA, Woman, Certification, Breast cancer, Curriculum, GLC, CEM, RSNA, Physician, 2D, Imaging, Organization, Muhimbili National Hospital, MNH

MNH at MUHAS is a public hospital serving Dar es Salaam, the largest city in Tanzania, and did not have a working mammography machine.

Key Points: 
  • MNH at MUHAS is a public hospital serving Dar es Salaam, the largest city in Tanzania, and did not have a working mammography machine.
  • To help improve radiology education and patient care around the world, RSNA developed the Global Learning Center (GLC) program that works to create learning centers with established radiology departments based in low- or middle-resourced countries, like Tanzania.
  • “GE HealthCare is committed to helping reduce disparities in care and improving access to medical imaging worldwide.
  • “With breast cancer mortality rates in Tanzania among the highest globally, our work with RSNA will help bring much-needed mammography technology to MUHAS.

RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate

Retrieved on: 
Tuesday, April 16, 2024
Education, Mortality, MUHAS, Cancer, Radiology, Learning, Mammography, GE HealthCare, NNSA, Woman, Certification, Breast cancer, Curriculum, GLC, Nursing, CEM, RSNA, Physician, National Nuclear Security Administration, Diagnosis, Health, 2D, Imaging, Organization, Muhimbili National Hospital, MNH, Medical imaging

The project aims to help lower Tanzania's 50% breast cancer mortality rate through early detection and efforts to expand clinical education.

Key Points: 
  • The project aims to help lower Tanzania's 50% breast cancer mortality rate through early detection and efforts to expand clinical education.
  • [2] Additionally, the lifetime risk for developing breast cancer is approximately one in twenty, and approximately half of all women diagnosed with breast cancer in the country die of the disease.
  • "With breast cancer mortality rates in Tanzania among the highest globally, our work with RSNA will help bring much-needed mammography technology to MUHAS.
  • GE HealthCare and RSNA will join the team at Muhimbili National Hospital to celebrate this collaboration on Wednesday, April 17, 2024 at the breast center's unveiling.

Caring Cross and the Global Gene Therapy Initiative Deliver Presentations at the "Advanced Therapy for Sickle Cell Disease in Africa" Meeting at Muhimbili University of Health and Allied Sciences

Retrieved on: 
Tuesday, February 8, 2022
Thalassemia, Global Genes, SCD, Cell, Muhimbili University of Health and Allied Sciences, Ministry of Education (Malaysia), Aga Khan Hospital, Dar es Salaam, Gene, Joint Clinical Research Centre, HIV, Sickle cell disease, World, Bill & Melinda Gates Foundation, MUHAS, Program, Patient, JCRC, Method, Fred Hutchinson Cancer Research Center, Physician, Association, Dropull, World Health Organization, Haematopoietic system, Associate, Pharmaceutical industry, Medical device

"Caring Cross ishonored to participate in this important meeting and support the mission to accelerate the introduction of gene therapies for Sickle Cell Disease to Africa."

Key Points: 
  • "Caring Cross ishonored to participate in this important meeting and support the mission to accelerate the introduction of gene therapies for Sickle Cell Disease to Africa."
  • Dr. Adair commented: "The Global Gene Therapy Initiative is pleased to participate in this important meeting and support the advancement of curative interventions for Sickle Cell Disease.
  • Currently, Caring Cross is advancing several initiatives that aim to improve the accessibility, affordability and applicability of CAR-T technology and stem cell gene therapy.
  • A stem cell gene therapy for Sickle Cell Disease and Beta-Thalassemia is also in development.